- Revenue increases 5 percent to $22 billion
- Operating earnings up 9 percent to $490 million - Diluted earnings per share from continuing operations rise 15 percent to
$0.82 per share - Non-GAAP diluted EPS from continuing operations increases 15 percent to
$0.86 per share - Full year EPS guidance reaffirmed, outlook revised for Healthcare Supply
Chain Services-Pharmaceutical segment
DUBLIN, Ohio, Nov. 5 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today reported a 15 percent increase in earnings per share during its first quarter, led by strong profit growth in its clinical and medical products businesses and ongoing programs to repurchase shares and streamline operations.
For the quarter ended Sept. 30, revenue increased 5 percent to $22 billion, operating earnings increased 9 percent to $490 million and earnings per share from continuing operations rose 15 percent to $0.82, or $0.86(1) on a non-GAAP basis.
"Our first quarter results were solid and led by very strong performance in our Clinical and Medical Products sector, which now accounts for 30 percent of segment profits," said R. Kerry Clark, chief executive officer of Cardinal Health.
Cardinal Health also reaffirmed its annual earnings-per-share guidance, while lowering the profit outlook for its Healthcare Supply Chain Services- Pharmaceutical segment. The company continues to expect a strong second half of the fiscal year, led by continued growth in clinical and medical products and a significant increase in generic product introductions.
"We are disappointed with the performance in our Healthcare Supply
Chain Services-Pharmaceutical segment, but have a positive outlook for the
second half of the fiscal year for the company," Clark said. "Our Clinical
|SOURCE Cardinal Health, Inc.|
Copyright©2007 PR Newswire.
All rights reserved